Cns Pharmaceuticals, Inc. (CNSP) — S-1/A Filings
All S-1/A filings from Cns Pharmaceuticals, Inc.. Browse 4 S-1/A reports with AI-powered summaries and risk analysis.
S-1/A Filings (4)
-
CNS Pharmaceuticals Files S-1/A Amendment
— May 12, 2025 Risk: medium
CNS Pharmaceuticals, Inc. filed an S-1/A amendment on May 12, 2025, for its registration statement. The company, incorporated in Nevada, is in the pharmaceutica -
CNS Pharmaceuticals Files S-1/A Amendment
— Jul 19, 2024 Risk: medium
CNS Pharmaceuticals, Inc. filed an S-1/A amendment on July 19, 2024, to update its registration statement. The company, incorporated in Nevada with its principa -
CNS Pharmaceuticals Files S-1/A Amendment
— Jan 22, 2024 Risk: low
CNS Pharmaceuticals, Inc. (CNSP) filed a Amended IPO Registration (S-1/A) with the SEC on January 22, 2024. CNS Pharmaceuticals, Inc. filed an S-1/A amendment o -
CNS Pharmaceuticals Files S-1/A Amendment
— Jan 10, 2024 Risk: low
CNS Pharmaceuticals, Inc. (CNSP) filed a Amended IPO Registration (S-1/A) with the SEC on January 10, 2024. CNS Pharmaceuticals, Inc. filed an S-1/A amendment o
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX